CALM3 and neoplasm: A variety of CaM antagonists have been assayed for their ability to inhibit the enhanced migratory capacity of tumor cells, which is required for their invasiveness into adjacent tissues as well as blood and lymphatic dissemination of individual and, most efficiently, clusters of neoplastic cells forming metastasis (see Table 2).